Skip to main content

Not investment advice.Read full disclaimer

Healthcare · Biotechnology

52W Range

40thpctl

Volume

1.88×avg

Market Cap

39.84MUSD

P/E Ratio

-7.4TTM

Div Yield

-ann

Continue with finqOS

Explore Alterity Therapeutics Limited's financials

Income statements, balance sheets, and cash flows - annual and quarterly, going back 20+ years.

Start Free Trial→Sign In

14-day free trial · No credit card required

Alterity Therapeutics Limited

ATHENASDAQ Capital Market·USD·Closed

Alterity Therapeutics Limited

ATHENASDAQ·USD·Closed

$4.39

+6.93%

$4.39

+$0.28 (6.93%)

52W Range

40thpctl

Volume

1.88×avg

Mkt Cap

39.84MUSD

P/E

-7.4TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

ATHE: Alterity Therapeutics Limited Financial Statements & Revenue | finqOS